|
1
|
Lesiak A, Slowik-Rylska M, Rogowski-Tylman
M, Sysa-Jedrzejowska A, Norval M and Narbutt J: Risk factors in
Central Poland for the development of superficial and nodular basal
cell carcinomas. Arch Med Sci. 6:270–275. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tilli CM, Van Steensel MA, Krekels GA,
Neumann HA and Ramaekers FC: Molecular aetiology and pathogenesis
of basal cell carcinoma. Br J Dermatol. 152:1108–1124. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Miller DL and Weinstock MA: Nonmelanoma
skin cancer in the United States: Incidence. J Am Acad Dermatol.
30:774–778. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Daya-Grosjean L and Couvé-Privat S: Sonic
hedgehog signaling in basal cell carcinomas. Cancer Lett.
225:181–192. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dessinioti C, Antoniou C, Katsambas A and
Stratigos AJ: Basal cell carcinoma: Whats new under the sun.
Photochem Photobiol. 86:481–491. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Corona R, Dogliotti E, DErrico M, Sera F,
Iavarone I, Baliva G, Chinni LM, Gobello T, Mazzanti C, Puddu P and
Pasquini P: Risk factors for basal cell carcinoma in a
Mediterranean population: Role of recreational sun exposure early
in life. Arch Dermatol. 137:1162–1168. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Green A, Battistutta D, Hart V, Leslie D
and Weedon D: Skin cancer in a subtropical Australian population:
Incidence and lack of association with occupation. The Nambour
Study Group. Am J Epidemiol. 144:1034–1040. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gallagher RP and Lee TK: Adverse effects
of ultraviolet radiation: A brief review. Prog Biophys Mol Biol.
92:119–131. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Oberyszyn TM: Non-melanoma skin cancer:
Importance of gender, immunosuppressive status and vitamin D.
Cancer Lett. 261:127–136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lupi O: Correlations between the Sonic
Hedgehog Pathway and basal cell carcinoma. Int J Dermatol.
46:1113–1117. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Siegel PM and Massagué J: Cytostatic and
apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev
Cancer. 3:807–820. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yucel T, Mutnal A, Fay K, Fligiel SE, Wang
T, Johnson T, Baker SR and Varani J: Matrix metalloproteinase
expression in basal cell carcinoma: Relationship between enzyme
profile and collagen fragmentation pattern. Exp Mol Pathol.
79:151–160. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Poswar FO, Fraga CA, Farias LC,
Feltenberger JD, Cruz VP, Santos SH, Silveira CM, de Paula AM and
Guimarães AL: Immunohistochemical analysis of TIMP-3 and MMP-9 in
actinic keratosis, squamous cell carcinoma of the skin, and basal
cell carcinoma. Pathol Res Pract. 209:705–709. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Quintanilla-Dieck MJ, Codriansky K, Keady
M, Bhawan J and Rünger TM: Cathepsin K in melanoma invasion. J
Invest Dermatol. 128:2281–2288. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ishida M, Kojima F and Okabe H:
Cathepsin-K expression in basal cell carcinoma. J Eur Acad
Dermatology Venereol. 27:e128–e130. 2013. View Article : Google Scholar
|
|
16
|
Yan X, Takahara M, Xie L, Oda Y, Nakahara
T, Uchi H, Takeuchi S, Tu Y, Moroi Y and Furue M: Stromal
expression of cathepsin-K in squamous cell carcinoma. J Eur Acad
Dermatology Venereol. 25:362–365. 2011. View Article : Google Scholar
|
|
17
|
McClintock D, Ratner D, Lokuge M, Owens
DM, Gordon LB, Collins FS and Djabali K: The mutant form of lamin A
that causes Hutchinson-Gilford progeria is a biomarker of cellular
aging in human skin. PLoS One. 2:e12692007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zuber TJ: Punch biopsy of the skin. Am Fam
Physician. 65(1155–1158): 1161–1162, 1164. 2002.
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ting PT, Kasper R and Arlette JP:
Metastatic basal cell carcinoma: Report of two cases and literature
review. J Cutan Med Surg. 9:10–15. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Han G and Wang XJ: Roles of TGFβ signaling
Smads in squamous cell carcinoma. Cell Biosci. 2011(1): 412011.
View Article : Google Scholar
|
|
22
|
Cui W, Fowlis DJ, Bryson S, Duffie E,
Ireland H, Balmain A and Akhurst RJ: TGFbeta1 inhibits the
formation of benign skin tumors, but enhances progression to
invasive spindle carcinomas in transgenic mice. Cell. 86:531–542.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stalińska L and Ferenc T: The role of
TGF-beta in cell cycle regulation. Postepy Hig Med Dosw (Online).
59:441–449. 2005.(In Polish). PubMed/NCBI
|
|
24
|
Bierie B and Moses HL: Tumour
microenvironment: TGFbeta: The molecular Jekyll and Hyde of cancer.
Nat Rev Cancer. 6:506–520. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hata A, Shi Y and Massagué J: TGF-beta
signaling and cancer: Structural and functional consequences of
mutations in Smads. Mol Med Today. 4:257–262. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li AG, Lu SL, Han G, Kulesz-Martin M and
Wang XJ: Current view of the role of transforming growth factor
beta 1 in skin carcinogenesis. J Investig Dermatol Symp Proc.
10:110–117. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schmid P, Itin P and Rufli T: In situ
analysis of transforming growth factors-beta (TGF-beta 1, TGF-beta
2, TGF-beta 3) and TGF-beta type II receptor expression in basal
cell carcinomas. Br J Dermatol. 134:1044–1051. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gambichler T, Skrygan M, Kaczmarczyk JM,
Hyun J, Tomi NS, Sommer A, Bechara FG, Boms S, Brockmeyer NH,
Altmeyer P and Kreuter A: Increased expression of TGF-beta/Smad
proteins in basal cell carcinoma. Eur J Med Res. 12:509–514.
2007.PubMed/NCBI
|
|
29
|
Furue M, Kato M, Nakamura K, Nashiro K,
Kikuchi K, Okochi H, Miyazono K and Tamaki K: Dysregulated
expression of transforming growth factor beta and its type-I and
type-II receptors in basal-cell carcinoma. Int J Cancer.
71:505–509. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Witek K, Goździalska A and Jaśkiewicz J:
Metaloproteinazy jako nowy wskaźnik diagnostyczny nowotworów skóry.
Stan skóry wykładnikiem stanu zdrowia. (red.) Anna Goździalska,
Jerzy Jaśkiewicz. Kraków: Oficyna Wydawnicza AFM. 19–29. 2012.
|
|
31
|
Śliwowska I and Kopczyński Z:
Metaloproteinazy macierzy zewnątrzkomórkowej-charakterystyka
biochemiczna i kliniczna wartość oznaczania u chorych na raka
piersi. Wsp Onkol. 9:327–335. 2005.(In Polish).
|
|
32
|
Lukaszewicz-Zajac M, Mroczko B and
Szmitkowski M: The significance of metalloproteinases and their
inhibitors in gastric cancer. Postepy Hig Med Dosw (Online).
63:258–265. 2009.(In Polish). PubMed/NCBI
|
|
33
|
Groblewska M, Mroczko B and Szmitkowski M:
The role of selected matrix metalloproteinases and their inhibitors
in colorectal cancer development. Postepy Hig Med Dosw (Online).
64:22–30. 2010.(In Polish). PubMed/NCBI
|
|
34
|
Kwiatkowski P: The role of matrix
metalloproteinases in tumour invasion. Pol Ann Med. 43–50.
2008.
|
|
35
|
Wyględowska-Kania M, Gola J, Fila-Daniłow
A, Wcisło-Dziadecka D, Brzezińska-Wcisło L and Mazurek U: Molecular
studies of non-melanoma skin cancers. Borgis-Postępy Nauk Med.
752–757. 2012.
|
|
36
|
Monhian N, Jewett BS, Baker SR and Varani
J: Matrix metalloproteinase expression in normal skin associated
with basal cell carcinoma and in distal skin from the same
patients. Arch Facial Plast Surg. 7:238–243. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Varani J, Hattori Y, Chi Y, Schmidt T,
Perone P, Zeigler ME, Fader DJ and Johnson TM: Collagenolytic and
gelatinolytic matrix metalloproteinases and their inhibitors in
basal cell carcinoma of skin: Comparison with normal skin. Br J
Cancer. 82:657–665. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gutiérrez-Fernández A, Fueyo A, Folgueras
AR, Garabaya C, Pennington CJ, Pilgrim S, Edwards DR, Holliday DL,
Jones JL, Span PN, et al: Matrix metalloproteinase-8 functions as a
metastasis suppressor through modulation of tumor cell adhesion and
invasion. Cancer Res. 68:2755–2763. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Goździalska Anna, Gawędzka Anna, Brzewski
Paweł and Anna Wojas-Pelc JJ: Skin cancer diagnosis based on the
determination of the expression metalloproteinases.
Interdescyplinarne aspekty Nauk o zdrowiu. 41–56. 2010.
|
|
40
|
Rao Q, Wang Y, Xia QY, Shi SS, Shen Q, Tu
P, Shi QL, Zhou XJ and Wu B: Cathepsin-K in the immunohistochemical
diagnosis of melanocytic lesions. Int J Clin Exp Pathol.
7:1132–1139. 2014.PubMed/NCBI
|
|
41
|
Zheng Y, Chen H, Lai W, Xu Q, Liu C, Wu L
and Maibach HI: Cathepsin D repairing role in photodamaged skin
barrier. Skin Pharmacol Physiol. 28:97–102. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Prokocimer M, Davidovich M, Nissim-Rafinia
M, Wiesel-Motiuk N, Bar DZ, Barkan R, Meshorer E and Gruenbaum Y:
Nuclear lamins: Key regulators of nuclear structure and activities.
J Cell Mol Med. 13:1059–1085. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Venables RS, McLean S, Luny D, Moteleb E,
Morley S, Quinlan RA, Lane EB and Hutchison CJ: Expression of
individual lamins in basal cell carcinomas of the skin. Br J
Cancer. 84:512–519. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Oguchi M, Sagara J, Matsumoto K, Saida T
and Taniguchi S: Expression of lamins depends on epidermal
differentiation and transformation. Br J Dermatol. 147:853–858.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tilli CM, Ramaekers FC, Broers JL,
Hutchison CJ and Neumann HA: Lamin expression in normal human skin,
actinic keratosis, squamous cell carcinoma and basal cell
carcinoma. Br J Dermatol. 148:102–109. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Scaffidi P and Misteli T: Lamin
A-dependent nuclear defects in human aging. Science. 312:1059–1063.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lin W, Huang J, Yuan Z, Feng S, Xie Y and
Ma W: Protein kinase C inhibitor chelerythrine selectively inhibits
proliferation of triple-negative breast cancer cells. Sci Rep.
7:20222017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Baudhuin M, Lamoureux F, Jacques C,
Calleja Rodriguez L, Quillard T, Charrier C, Amiaud J, Berreur M,
Brounais-LeRoyer B, Owen R, et al: Inhibition of BET proteins and
epigenetic signaling as a potential treatment for osteoporosis.
Bone. 94:10–21. 2017. View Article : Google Scholar : PubMed/NCBI
|
